A Mass Action Model of a Fibroblast Growth Factor Signaling Pathway and Its Simplification

We consider a kinetic law of mass action model for Fibroblast Growth Factor (FGF) signaling, focusing on the induction of the RAS-MAP kinase pathway via GRB2 binding. Our biologically simple model suffers a combinatorial explosion in the number of differential equations required to simulate the system. In addition to numerically solving the full model, we show that it can be accurately simplified. This requires combining matched asymptotics, the quasi-steady state hypothesis, and the fact subsets of the equations decouple asymptotically. Both the full and simplified models reproduce the qualitative dynamics observed experimentally and in previous stochastic models. The simplified model also elucidates both the qualitative features of GRB2 binding and the complex relationship between SHP2 levels, the rate SHP2 induces dephosphorylation and levels of bound GRB2. In addition to providing insight into the important and redundant features of FGF signaling, such work further highlights the usefulness of numerous simplification techniques in the study of mass action models of signal transduction, as also illustrated recently by Borisov and co-workers (Borisov et al. in Biophys. J. 89, 951–66, 2005, Biosystems 83, 152–66, 2006; Kiyatkin et al. in J. Biol. Chem. 281, 19925–9938, 2006). These developments will facilitate the construction of tractable models of FGF signaling, incorporating further biological realism, such as spatial effects or realistic binding stoichiometries, despite a more severe combinatorial explosion associated with the latter.

[1]  D. Ambrosetti,et al.  Mechanisms underlying differential responses to FGF signaling. , 2005, Cytokine & growth factor reviews.

[2]  G. Krueger,et al.  Psoriasis--recent advances in understanding its pathogenesis and treatment. , 2005, Journal of the American Academy of Dermatology.

[3]  Boris N Kholodenko,et al.  Scaffolding Protein Grb2-associated Binder 1 Sustains Epidermal Growth Factor-induced Mitogenic and Survival Signaling by Multiple Positive Feedback Loops* , 2006, Journal of Biological Chemistry.

[4]  B. Kholodenko,et al.  Signaling through receptors and scaffolds: independent interactions reduce combinatorial complexity. , 2005, Biophysical journal.

[5]  D. Lauffenburger,et al.  Physicochemical modelling of cell signalling pathways , 2006, Nature Cell Biology.

[6]  Herbert M. Sauro,et al.  Complexity Reduction of Biochemical Networks , 2006, Proceedings of the 2006 Winter Simulation Conference.

[7]  M. Krasnow,et al.  Sprouty proteins are in vivo targets of Corkscrew/SHP-2 tyrosine phosphatases , 2006, Development.

[8]  J. Heath,et al.  FRS2-dependent SRC activation is required for fibroblast growth factor receptor-induced phosphorylation of Sprouty and suppression of ERK activity , 2004, Journal of Cell Science.

[9]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[10]  B. Thisse,et al.  Functions and regulations of fibroblast growth factor signaling during embryonic development. , 2005, Developmental biology.

[11]  G. Guy,et al.  Evidence for Direct Interaction between Sprouty and Cbl* , 2001, The Journal of Biological Chemistry.

[12]  Hiroaki Kitano,et al.  The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models , 2003, Bioinform..

[13]  E. Gilles,et al.  Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors , 2002, Nature Biotechnology.

[14]  Vadim N Biktashev,et al.  Comparison of asymptotics of heart and nerve excitability. , 2003, Physical review. E, Statistical, nonlinear, and soft matter physics.

[15]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[16]  A. Wells,et al.  Mitogenic signaling from the egf receptor is attenuated by a phospholipase C-gamma/protein kinase C feedback mechanism. , 1996, Molecular biology of the cell.

[17]  E. Nishida,et al.  Shp2, an SH2-containing Protein-tyrosine Phosphatase, Positively Regulates Receptor Tyrosine Kinase Signaling by Dephosphorylating and Inactivating the Inhibitor Sprouty* , 2004, Journal of Biological Chemistry.

[18]  Kwang-Hyun Cho,et al.  Modeling and simulation of intracellular dynamics: choosing an appropriate framework , 2004, IEEE Transactions on NanoBioscience.

[19]  V. P. Eswarakumar,et al.  Cellular signaling by fibroblast growth factor receptors. , 2005, Cytokine & growth factor reviews.

[20]  J. Schlessinger,et al.  Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[21]  S. Orszag,et al.  Advanced mathematical methods for scientists and engineers I: asymptotic methods and perturbation theory. , 1999 .

[22]  Raymond R. Hill,et al.  Editorial: introduction to the special issue , 2003 .

[23]  R. Taboła,et al.  Epidermal Growth Factor Receptor (EGF-R) in Dupuytren’s Disease , 2005, Journal of hand surgery.

[24]  Marta Z. Kwiatkowska,et al.  Probabilistic model checking of complex biological pathways , 2008, Theor. Comput. Sci..

[25]  A. Wilkie Bad bones, absent smell, selfish testes: The pleiotropic consequences of human FGF receptor mutations , 2005 .

[26]  Jacob Piehler,et al.  Determination of the two-dimensional interaction rate constants of a cytokine receptor complex. , 2006, Biophysical journal.

[27]  Wolfgang Linert,et al.  The Law of Mass Action , 2001 .

[28]  A. Citri,et al.  EGF–ERBB signalling: towards the systems level , 2006, Nature Reviews Molecular Cell Biology.

[29]  P. McSharry,et al.  Mathematical and computational techniques to deduce complex biochemical reaction mechanisms. , 2004, Progress in biophysics and molecular biology.

[30]  Marta Z. Kwiatkowska,et al.  Simulation and Verification for Computational Modelling of Signalling Pathways , 2006, Proceedings of the 2006 Winter Simulation Conference.

[31]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[32]  Erez M. Bublil,et al.  The EGF receptor family : spearheading a merger of signaling and therapeutics , 2007 .

[33]  A. Yoshimura,et al.  Model analysis of difference between EGF pathway and FGF pathway. , 2004, Biochemical and biophysical research communications.

[34]  M. Hayman,et al.  Molecular Mechanism for a Role of SHP2 in Epidermal Growth Factor Receptor Signaling , 2003, Molecular and Cellular Biology.

[35]  Shaun K Olsen,et al.  Structural basis for fibroblast growth factor receptor activation. , 2005, Cytokine & growth factor reviews.

[36]  K. Ohta,et al.  Activation of epidermal growth factor receptor via CCR3 in bronchial epithelial cells. , 2004, Biochemical and biophysical research communications.

[37]  B. Kennedy,et al.  Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis , 2007, Nature Genetics.

[38]  Boris N Kholodenko,et al.  Trading the micro-world of combinatorial complexity for the macro-world of protein interaction domains. , 2006, Bio Systems.

[39]  Kathy Chen,et al.  Network dynamics and cell physiology , 2001, Nature Reviews Molecular Cell Biology.

[40]  C. Dickson,et al.  Fibroblast growth factor signaling in tumorigenesis. , 2005, Cytokine & growth factor reviews.

[41]  Gavin MacBeath,et al.  State-based discovery: a multidimensional screen for small-molecule modulators of EGF signaling , 2006, Nature Methods.

[42]  Eric Bullinger,et al.  Approximations and their consequences for dynamic modelling of signal transduction pathways. , 2007, Mathematical biosciences.

[43]  James Shipman,et al.  Wave Motion , 2006 .

[44]  N. Hacohen,et al.  Sprouty: a common antagonist of FGF and EGF signaling pathways in Drosophila. , 1999, Development.

[45]  N. Rashevsky,et al.  Mathematical biology , 1961, Connecticut medicine.

[46]  L. Segel,et al.  Law of mass action , 1992, Nature.